• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Avantax Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    9/11/23 1:38:46 PM ET
    $AAMC
    $ACB
    $AIH
    $AVTA
    Real Estate
    Finance
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $AAMC alert in real time by email

    Gainers

    • Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.
    • NovaBay Pharmaceuticals, Inc. (NYSE:NBY) shares climbed 62.9% to $1.01 after the company granted Biostem Technologies the right to commercialize amniotic tissue allograft, which is intended for use as a protective covering during the repair of ocular surfaces.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) surged 38% to $1.9167. Plus Therapeutics received $1.9 million advance payment from CPRIT.
    • Avantax, Inc. (NASDAQ:AVTA) rose 27.5% to $25.45 as the company agreed to be acquired by Cetera Holdings for $26 per share in cash.
    • Yoshiharu Global Co. (NASDAQ:YOSH) gained 24% to $0.4344. Yoshiharu signed a non-binding Memorandum of Understanding to acquire Jjanga LLC, HJH LLC and Ramen Aku LLC Restaurants in Las Vegas.
    • Aurora Cannabis Inc. (NASDAQ:ACB) jumped 22.2% to $0.6463. Aurora Cannabis repurchased an aggregate of roughly CA$12.3 million ($9 million) principal amount of its convertible senior notes in multiple transactions between Aug. 16 and Sept. 8, 2023.
    • Versus Systems Inc. (NASDAQ:VS) shares gained 20.8% to $0.3145.
    • Hostess Brands, Inc. (NASDAQ:TWNK) rose 18.9% to $33.42 after J.M. Smucker announced it will acquire the company.
    • Canopy Growth Corporation (NASDAQ:CGC) shares gained 17.5% to $1.0950.
    • Virco Mfg. Corporation (NASDAQ:VIRC) rose 13.9% to $5.24 following better-than-expected quarterly results.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) jumped 12.5% to $6.21. Marker Therapeutics announced the preliminary results of the first participant treated with MT-601, its multi-tumor associated antigen-specific T Cell product targeting 6 Taas, in the Phase 1 multicenter APOLLO trial.
    • Altisource Asset Management Corporation (NYSE:AAMC) gained 12.5% to $7.10. Altisource Asset Management reported a stock dividend in lieu of a stock split and appointment of Richard Rodick as new CFO.
    • Mullen Automotive, Inc. (NASDAQ:MULN) rose 12% to $0.4670.
    • Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) rose 11.5% to $0.9129. Aesthetic Medical International announced receipt of Nasdaq notification letter regarding minimum bid price deficiency.
    • Bowlero Corp. (NYSE:BOWL) gained 11.3% to $11.27 following quarterly results.
    • 1-800-FLOWERS.COM, Inc. (NASDAQ:FLWS) rose 9.7% to $6.96.
    • Kaixin Auto Holdings (NASDAQ:KXIN) gained 9.5% to $0.2802. Kaixin Auto inked a non-binding acquisition term sheet with WM Motor.
    • BeiGene, Ltd. (NASDAQ:BGNE) climbed 9% to $209.91 amid a report the company is working with Luye to commercialize a breast cancer treatment in China.
    • Carlisle Companies Incorporated (NYSE:CSL) gained 8.1% to $271.62.
    • BlackBerry Limited (NYSE:BB) gained 7.6% to $4.91. BlackBerry launched 'intrinsically safe' certified solution for hazardous materials carriers.
    • Tesla, Inc. (NASDAQ:TSLA) shares rose 5.5% to $262.24. Morgan Stanley upgraded Tesla from Equal-Weight to Overweight and raised the price target from $250 to $400.

    Losers

    • SigmaTron International, Inc. (NASDAQ:SGMA) shares dipped 46.6% to $4.03 after the company released first-quarter earnings.
    • Tenon Medical, Inc. (NASDAQ:TNON) fell 31.8% to $0.1711 after the company announced proposed public offering of common stock.
    • Solowin Holdings (NASDAQ:SWIN) fell 28.4% to $3.5163. Solowin Holdings announced closing of initial public offering.
    • Axcella Health Inc. (NASDAQ:AXLA) fell 22.7% to $0.7572 after jumping more than 70% on Friday.
    • CXApp Inc. (NASDAQ:CXAI) fell 17.8% to $2.70.
    • WANG & LEE GROUP, Inc. (NASDAQ:WLGS) fell 17.8% to $0.83 after surging around 22% on Friday.
    • Courtside Group, Inc. (NASDAQ:PODC) shares fell 17.7% to $3.610 after declining 45% on Friday.
    • Hitek Global Inc. (NASDAQ:HKIT) fell 16.2% to $2.6575 after dipping 25% on Friday.
    • IHS Holding Limited (NYSE:IHS) shares dipped 15.7% to $5.01.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) declined 11.4% to $1.0099.
    • Elutia Inc. (NASDAQ:ELUT) fell 11.1% to $1.32.
    • Granite Ridge Resources, Inc. (NYSE:GRNT) declined 11% to $6.67. Granite Ridge Resources launched a secondary public offering of 7.1 million shares by selling stockholders.
    • Nuwellis, Inc. (NASDAQ:NUWE) fell 10.7% to $1.7150 after gaining around 7% on Friday.
    • Impel Pharmaceuticals Inc. (NASDAQ:IMPL) shares fell 10% to $0.3789 after gaining 10% on Friday.
    • Neptune Wellness Solutions Inc. (NASDAQ:NEPT) tumbled 10% to $6.35.
    • Puyi Inc. (NASDAQ:PUYI) fell 9.6% to $5.20.
    • Loop Media, Inc. (NASDAQ:LPTV) declined 9.2% to $0.5725.
    • Butterfly Network, Inc. (NYSE:BFLY) fell 8.8% to $1.7050.
    • Virgin Galactic Holdings, Inc. (NYSE:SPCE) declined 8.3% to $2.0998.
    • Magenta Therapeutics, Inc. (NASDAQ:MGTA) fell 8.1% to $0.6969.
    • The J. M. Smucker Company (NYSE:SJM) fell 7.9% to $130.39 after the company announced it will acquire Hostess Brands.
    • Cingulate Inc. (NASDAQ:CING) shares fell 7.8% to $0.5324 after the company said Werth Family Investment Associates, LLC has converted $5.8 million of debt and accrued interest into Cingulate equity, at a conversion price of $0.85 per share.
    • SmartRent, Inc. (NYSE:SMRT) fell 7.5% to $2.84.

     

    Now Read This: Lattice Semiconductor, Navitas Semiconductor And 2 Other Stocks Insiders Are Sellingr

    Get the next $AAMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAMC
    $ACB
    $AIH
    $AVTA

    CompanyDatePrice TargetRatingAnalyst
    Tesla Inc.
    $TSLA
    3/4/2026$460.00Buy
    BofA Securities
    The J.M. Smucker Company
    $SJM
    2/23/2026$130.00Neutral → Buy
    BofA Securities
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    Tesla Inc.
    $TSLA
    1/30/2026$150.00 → $145.00Underweight
    Analyst
    Carlisle Companies Incorporated
    $CSL
    1/30/2026Mkt Perform
    William Blair
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    The J.M. Smucker Company
    $SJM
    1/16/2026$105.00Overweight → Equal-Weight
    Morgan Stanley
    More analyst ratings

    $AAMC
    $ACB
    $AIH
    $AVTA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for TRUDHESA issued to IMPEL NEUROPHARMA INC

    Submission status for IMPEL NEUROPHARMA INC's drug TRUDHESA (ORIG-1) with active ingredient DIHYDROERGOTAMINE MESYLATE has changed to 'Approval' on 09/02/2021. Application Category: NDA, Application Number: 213436, Application Classification: Type 5 - New Formulation or New Manufacturer

    9/13/21 2:21:35 PM ET
    $IMPL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DIHYDROERGOTAMINE MESYLATE issued to IMPEL NEUROPHARMA INC

    Submission status for IMPEL NEUROPHARMA INC's drug DIHYDROERGOTAMINE MESYLATE (ORIG-1) with active ingredient DIHYDROERGOTAMINE MESYLATE has changed to 'Approval' on 09/02/2021. Application Category: NDA, Application Number: 213436, Application Classification: Type 5 - New Formulation or New Manufacturer

    9/7/21 1:04:43 PM ET
    $IMPL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $ACB
    $AIH
    $AVTA
    SEC Filings

    View All

    SEC Form 144 filed by Tesla Inc.

    144 - Tesla, Inc. (0001318605) (Subject)

    3/6/26 5:42:03 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form RW filed by PLUS THERAPEUTICS Inc.

    RW - PLUS THERAPEUTICS, INC. (0001095981) (Filer)

    3/6/26 4:05:32 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    SEC Form 10-K filed by Granite Ridge Resources Inc.

    10-K - Granite Ridge Resources, Inc. (0001928446) (Filer)

    3/5/26 8:26:33 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    $AAMC
    $ACB
    $AIH
    $AVTA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Devivo Joseph sold $1,788,291 worth of shares (482,149 units at $3.71), decreasing direct ownership by 6% to 8,030,899 units (SEC Form 4)

    4 - Butterfly Network, Inc. (0001804176) (Issuer)

    3/6/26 4:05:36 PM ET
    $BFLY
    Medical Electronics
    Health Care

    President and CEO Farquharson Tyler was granted 47,656 shares, increasing direct ownership by 17% to 322,243 units (SEC Form 4)

    4 - Granite Ridge Resources, Inc. (0001928446) (Issuer)

    3/6/26 2:27:02 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    Chief Financial Officer Kettler Ronald Kyle was granted 17,110 shares, increasing direct ownership by 17% to 115,276 units (SEC Form 4)

    4 - Granite Ridge Resources, Inc. (0001928446) (Issuer)

    3/6/26 2:24:45 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    $AAMC
    $ACB
    $AIH
    $AVTA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Granite Ridge Resources, Inc. Reports Fourth Quarter and Full-Year 2025 Results and Provides Outlook for 2026

    Granite Ridge Resources, Inc. (NYSE:GRNT) ("Granite Ridge" or the "Company") today reported financial and operating results for the fourth quarter and full-year 2025 and provided initial guidance for 2026. Fourth Quarter 2025 Highlights Increased total production by 27% to 35,120 Boe/day (49% oil) including a 17% increase in oil production Reported net loss of $25.1 million, or $(0.19) per share, and Adjusted Net Income (non-GAAP) of $1.5 million, or $0.01 Adjusted Earnings Per Diluted Share (non-GAAP) Generated Adjusted EBITDAX (non-GAAP) of $69.5 million Invested $127.5 million of capital, placing online 67 gross (10.50 net) wells Declared a dividend of $0.11 per share

    3/5/26 4:19:00 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    PodcastOne (Nasdaq: PODC) Acquires Four Podcasts In Multi-Year Deals Bringing Network Total to 208; 6 Podcasts Added to Date in 2026

    LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- PodcastOne (NASDAQ:PODC), a leading publisher and podcast sales network, announced today that it has acquired multi-year exclusive sales and distribution rights to podcasts No Filter with host Zack Peter, Wellness Cafe with host Trinity Tondeleir, Daddy Issues with Violet Benson and Michelle Collins' eponymous podcast, Michelle Collins. "PodcastOne is dedicated to our quest to bring to our network the best, most diversified and cross genre podcasts. With the additions of No Filter, Wellness Cafe, Michelle Collins and being able to welcome back Daddy Issues, we've aligned with podcasts that pair well with our existing shows while continuing t

    3/5/26 8:00:00 AM ET
    $PODC
    Computer Software: Programming Data Processing
    Technology

    Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

    MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Stuart L. Goldstein, MD, FASN as Director of Clinical Strategy. Dr. Goldstein is internationally recognized as a pioneer in pediatric nephrology and critical care medicine. He serves as Director of the Center for Acute Care Nephrology, holds the Clark D. West Endowed Chair in Pediatric Nephrology at Cincinnati Children's Hospital Medical Center and is Professor of Pediatrics at the University of Cincinnati College of Medicine. His work has helped define the modern understand

    3/5/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AAMC
    $ACB
    $AIH
    $AVTA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Amin Tarang bought $99,801 worth of shares (880 units at $113.41), increasing direct ownership by 23% to 4,705 units (SEC Form 4)

    4 - J M SMUCKER Co (0000091419) (Issuer)

    3/3/26 4:41:12 PM ET
    $SJM
    Packaged Foods
    Consumer Staples

    SVP and CFO Callahan Jennifer L. bought $24,515 worth of shares (4,864 units at $5.04), increasing direct ownership by 2,494% to 5,059 units (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    2/10/26 7:00:20 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Schaffer Shane J. bought $34,317 worth of shares (6,809 units at $5.04) (SEC Form 4)

    4 - Cingulate Inc. (0001862150) (Issuer)

    2/10/26 7:00:19 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $ACB
    $AIH
    $AVTA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BofA Securities resumed coverage on Tesla with a new price target

    BofA Securities resumed coverage of Tesla with a rating of Buy and set a new price target of $460.00

    3/4/26 8:40:18 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    J.M. Smucker upgraded by BofA Securities with a new price target

    BofA Securities upgraded J.M. Smucker from Neutral to Buy and set a new price target of $130.00

    2/23/26 8:29:47 AM ET
    $SJM
    Packaged Foods
    Consumer Staples

    Tigress Financial resumed coverage on Tesla with a new price target

    Tigress Financial resumed coverage of Tesla with a rating of Buy and set a new price target of $550.00

    2/12/26 10:13:29 AM ET
    $TSLA
    Auto Manufacturing
    Industrials

    $AAMC
    $ACB
    $AIH
    $AVTA
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

    MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Stuart L. Goldstein, MD, FASN as Director of Clinical Strategy. Dr. Goldstein is internationally recognized as a pioneer in pediatric nephrology and critical care medicine. He serves as Director of the Center for Acute Care Nephrology, holds the Clark D. West Endowed Chair in Pediatric Nephrology at Cincinnati Children's Hospital Medical Center and is Professor of Pediatrics at the University of Cincinnati College of Medicine. His work has helped define the modern understand

    3/5/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market

    GAITHERSBURG, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced the appointment of Pete Ligotti as Chief Commercial Officer. Mr. Ligotti will lead the commercialization for NXT-41x, Elutia's next-generation antibiotic-eluting biomatrix being developed to improve outcomes in plastic and reconstructive surgery. NXT-41x is Elutia's next-generation antibiotic-eluting biomatrix, built on the Company's validated drug-eluting platform. Elutia is applying that platform in plastic and reconstructive surgery, where breast reconstruction represents the largest and most underserved opportuni

    3/2/26 8:00:00 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of David A. McDonald and Martin J. Emerson to its Board of Directors, effective February 24, 2026. The appointments strengthen the Company's board with complementary expertise in public company leadership, capital markets, and medical device commercialization. "These appointments reflect our continued focus on operational discipline and long-term value creation," said John Erb, President and CEO of Nuwellis. "Marty has led multiple medical device organizations through scali

    2/26/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $AAMC
    $ACB
    $AIH
    $AVTA
    Financials

    Live finance-specific insights

    View All

    Granite Ridge Resources, Inc. Reports Fourth Quarter and Full-Year 2025 Results and Provides Outlook for 2026

    Granite Ridge Resources, Inc. (NYSE:GRNT) ("Granite Ridge" or the "Company") today reported financial and operating results for the fourth quarter and full-year 2025 and provided initial guidance for 2026. Fourth Quarter 2025 Highlights Increased total production by 27% to 35,120 Boe/day (49% oil) including a 17% increase in oil production Reported net loss of $25.1 million, or $(0.19) per share, and Adjusted Net Income (non-GAAP) of $1.5 million, or $0.01 Adjusted Earnings Per Diluted Share (non-GAAP) Generated Adjusted EBITDAX (non-GAAP) of $69.5 million Invested $127.5 million of capital, placing online 67 gross (10.50 net) wells Declared a dividend of $0.11 per share

    3/5/26 4:19:00 PM ET
    $GRNT
    Oil & Gas Production
    Energy

    PodcastOne (Nasdaq: PODC) Acquires Four Podcasts In Multi-Year Deals Bringing Network Total to 208; 6 Podcasts Added to Date in 2026

    LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- PodcastOne (NASDAQ:PODC), a leading publisher and podcast sales network, announced today that it has acquired multi-year exclusive sales and distribution rights to podcasts No Filter with host Zack Peter, Wellness Cafe with host Trinity Tondeleir, Daddy Issues with Violet Benson and Michelle Collins' eponymous podcast, Michelle Collins. "PodcastOne is dedicated to our quest to bring to our network the best, most diversified and cross genre podcasts. With the additions of No Filter, Wellness Cafe, Michelle Collins and being able to welcome back Daddy Issues, we've aligned with podcasts that pair well with our existing shows while continuing t

    3/5/26 8:00:00 AM ET
    $PODC
    Computer Software: Programming Data Processing
    Technology

    SmartRent Reports Fourth Quarter and Full-Year 2025 Financial Results

    Company Delivers Fourth Quarter 2025 Year-Over-Year Revenue Growth, Positive Adjusted EBITDA, and Maintains Strong Liquidity SmartRent, Inc. (NYSE:SMRT) ("SmartRent" or the "Company"), a leading provider of smart communities and operations solutions for the rental housing industry, today reported financial results for the three and twelve months ended December 31, 2025. Fourth Quarter 2025 Highlights; Total Revenue of $36.5 million, up 3% from prior year. Annual Recurring Revenue ("ARR") increased by 13% year over year to $61.6 million, now representing 42% of total revenue. Net loss aggregated $3.2 million compared with $11.4 million in the same quarter prior year. Improvement

    3/4/26 8:00:00 AM ET
    $SMRT
    EDP Services
    Technology

    $AAMC
    $ACB
    $AIH
    $AVTA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BeiGene Ltd.

    SC 13D/A - BeiGene, Ltd. (0001651308) (Subject)

    12/10/24 9:30:34 PM ET
    $BGNE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BeiGene Ltd.

    SC 13D/A - BeiGene, Ltd. (0001651308) (Subject)

    12/4/24 4:05:33 PM ET
    $BGNE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Crinetics Pharmaceuticals Inc.

    SC 13G/A - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 7:55:29 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care